[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f9S-LC56GbiheMvKlV1-K-qDbV3j4bU74zJne_njbuOI":8,"$fQJVCJwmp5JqWtLTmXpxC6nI_uBy-xOiCFcDAHcIdm14":55,"$f-bGYmmrVSiy_3WPwAhPMjCZsfoF3nZucy4JodKdIy0M":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},68588,867283,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//o1oe1SwU3vlGsqy95secRlqRH2wkEV8k.png","王俊","烟台高新技术产业开发区医院","普通内科","主治医师",416,0,"结肠癌IV期治疗主要药物安全用药详解","","https://ystcdn.venuertc.com/venue/AI/b17ea64a-e216-4647-9ba5-4c51913bb04c.jpg","\u003Cdiv class=\"drug-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"drug-guide-title\">\n    结肠癌IV期治疗主要药物安全用药详解\n  \u003C/h1>\n  \u003Cdiv class=\"drug-guide-intro\">\n    说起来，针对结肠癌IV期的治疗，化疗和靶向药物是非常常见的选择。无论是静脉用药还是口服制剂，这些药物在实际使用过程中都需要把握一系列关键细节。本文将带你梳理6个最重要的用药注意点，帮助每位患者和家属都能科学、安全地使用相关药物，有效避免风险。\n  \u003C/div>\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-section-title\">\n      01 化疗药物的服用时间与给药方法 ⏰💉\n    \u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-bg\">\u003C/div>\n    \u003Cdiv class=\"drug-guide-section-content\">\n      化疗药物包含注射剂和口服片剂两大类。\u003Cbr>\n      \u003Cstrong>注射给药：\u003C/strong> 常以静脉输注为主，需在医院，由专业护士操作。给药前后必须保证静脉通畅，密切监控输液部位，防止渗漏或刺激反应。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>口服制剂：\u003C/strong> 应在餐后半小时至一小时内用温水整片吞服，避免食道刺激。某些药物（如卡培他滨，Capecitabine）需要注意与餐食时间的间隔，遵循说明书用法。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>正确做法：\u003C/strong>\n      \u003Cul>\n        \u003Cli>每次服药时间尽量固定，保持规律。\u003C/li>\n        \u003Cli>出现呕吐未能服药，需尽快补服，但绝不能自行加量。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-guide-tip\">\u003Cstrong>特别提醒：\u003C/strong> 静脉化疗需全程医疗监护，切勿自行动操作。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-section-title\">\n      02 药品剂型特点与正确使用 💊\n    \u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-bg\">\u003C/div>\n    \u003Cdiv class=\"drug-guide-section-content\">\n      结肠癌IV期治疗中，常用到肠溶片、长效注射剂等多种剂型。\u003Cbr>\n      \u003Cstrong>肠溶片:\u003C/strong> 例如卡培他滨应整片吞服，不能嚼碎、掰开，也不要溶解，否则影响药效释放，还可能增加胃部刺激。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>水剂/注射剂:\u003C/strong> 如奥沙利铂等，通常医院输液使用，不建议带离医院保存和使用。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>正确做法：\u003C/strong>\n      \u003Cul>\n        \u003Cli>服药时用200ml以上温水，避免用茶、咖啡、果汁等替代。\u003C/li>\n        \u003Cli>对于咽喉吞咽困难者，必须咨询医生能否更换为其他剂型。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-guide-tip\">不按建议剂型使用有可能导致药效不稳定或副作用增多。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-section-title\">\n      03 药物相互作用与联合用药 🚦\n    \u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-bg\">\u003C/div>\n    \u003Cdiv class=\"drug-guide-section-content\">\n      靶向药物和化疗药常与包括抗凝药、抗酸药在内的多种药物同服。\u003Cbr>\n      \u003Cstrong>例如：\u003C/strong>\n      \u003Cul>\n        \u003Cli>含铂类化疗药（如奥沙利铂）与氨基糖苷类抗生素合用，增加肾毒性风险。\u003C/li>\n        \u003Cli>卡培他滨与抗凝药（如华法林）合用时可能延长凝血时间。\u003C/li>\n        \u003Cli>\u003Cspan class=\"drug-guide-case\">有位患者在服用卡培他滨的同时服用了华法林，凝血指标明显波动，后经医生调整药量后恢复正常。\u003C/span>\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>正确做法：\u003C/strong>\n      \u003Cul>\n        \u003Cli>使用新药前主动告知医生本人的全部用药清单。\u003C/li>\n        \u003Cli>服药期间避免随意添加任何中药、保健品。\u003C/li>\n        \u003Cli>如用药期间需更改药物，务必让医生评估相互作用风险。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-guide-tip\">化疗和靶向药之间、与日常药物之间的相互作用不可忽视。联合用药时需密切指导。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-section-title\">\n      04 特殊人群的个体剂量调整 🧓👵\n    \u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-bg\">\u003C/div>\n    \u003Cdiv class=\"drug-guide-section-content\">\n      药品剂量并非一成不变，针对老年人、肝肾功能异常及孕妇哺乳期人群，需有针对性调整。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>老年患者：\u003C/strong> 往往需从常规剂量下限或部分减量开始，密切观察血象、肝肾指标变化。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>肝肾功能减退：\u003C/strong> 某些药物（如卡培他滨、伊立替康等）应避免使用或合理减量，具体依据生化检测结果调整。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>孕妇、哺乳期：\u003C/strong> 绝大多数化疗药物及靶向药物均不可用于孕期及哺乳期，用药方案需由专科医生评估制定。\n      \u003Cul>\n        \u003Cli class=\"drug-guide-case\">一位老年患者因肾功能减退，卡培他滨剂量仅使用常规量的50%，经过动态调整后达到血药浓度目标。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-guide-tip\">\u003Cstrong>需要注意：\u003C/strong> 所有特殊人群首次用药前均需个体评估，切勿照搬他人剂量。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-section-title\">\n      05 常见不良反应及其处理 ⚠️\n    \u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-bg\">\u003C/div>\n    \u003Cdiv class=\"drug-guide-section-content\">\n      在化疗和靶向治疗过程中，可能遇到一系列不良反应。\u003Cbr>\n      \u003Cstrong>最常见反应：\u003C/strong> 包括白细胞减少、口腔炎、恶心呕吐等。一些靶向药例如贝伐珠单抗可能引发高血压、蛋白尿。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>正确做法：\u003C/strong>\n      \u003Cul>\n        \u003Cli>定期检测血常规等核心指标，及时发现副作用。\u003C/li>\n        \u003Cli>轻微恶心、食欲差可适当调整饮食，必要时辅助用止吐药。\u003C/li>\n        \u003Cli>疑似药物相关严重反应（如皮疹、呼吸困难、黄疸等），应立即联系医生，部分可能需停药。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-guide-tip\">\n        \u003Cstrong>临床研究显示：\u003C/strong> 奥沙利铂常见神经毒性发生率达60%以上（Gamelin et al., 2002），但多为可逆反应，通过调整剂量或延长间隔可缓解。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-section-title\">\n      06 药品储存、有效期与失误处理 📦\n    \u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-bg\">\u003C/div>\n    \u003Cdiv class=\"drug-guide-section-content\">\n      保证药品有效性和安全性离不开正确的储存。\n      \u003Cbr>\u003Cbr>\n      \u003Cstrong>储存要求：\u003C/strong>\n      \u003Cul>\n        \u003Cli>常温(15-25°C)避光保存，避免高温、潮湿环境。\u003C/li>\n        \u003Cli>开封后的片剂请及时妥善密封，避免吸湿、变色。\u003C/li>\n        \u003Cli>针剂类药物如无特殊说明，仅限在医疗机构冷链保存。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>失误处理：\u003C/strong>\n      \u003Cul>\n        \u003Cli>如误服过量，应立即前往医院就医。\u003C/li>\n        \u003Cli>漏服一剂应尽快补服，离下次服药临近则跳过该次，避免加倍。\u003C/li>\n        \u003Cli>过期药品勿再服用，按照药店或垃圾分类标准处理。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-guide-tip\">储存条件不当，药效和安全性会降低。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \u003Csection class=\"drug-guide-section\">\n    \u003Ch2 class=\"drug-guide-section-title\">\n      07 靶向药、免疫药物专属安全注意事项 🛡️\n    \u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-bg\">\u003C/div>\n    \u003Cdiv class=\"drug-guide-section-content\">\n      \u003Cstrong>靶向药物：\u003C/strong> 常见如贝伐珠单抗、瑞戈非尼等。用药期间易有高血压、出血风险等特殊副作用。\n      \u003Cul>\n        \u003Cli>用药前检测血压，血压波动明显时暂停或调整用药。\u003C/li>\n        \u003Cli>如出现异常出血或伤口愈合差，须及时就医。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>免疫检查点抑制剂：\u003C/strong> 如纳武利尤单抗等，可能引起免疫相关不良反应，包括皮疹、内分泌变化等。\n      \u003Cul>\n        \u003Cli>按时复查肝肾、甲状腺等功能。\u003C/li>\n        \u003Cli>任何新出现的不适感，应第一时间报告给医生。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-guide-tip\">\n        \u003Cstrong>正确做法：\u003C/strong> 靶向和免疫用药期间的特殊异常不可自行处理，一切变动须医生指导。\n      \u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \u003Csection class=\"drug-guide-summary\">\n    \u003Ch2 class=\"drug-guide-section-title\">\n      总结与再提醒 🌿\n    \u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-content\">\n      针对结肠癌IV期治疗方案中的各类药物，安全、规范的使用方法关乎治疗疗效与生活质量。尤其要注意服药时间与细节、相互作用风险、特殊人群剂量，以及不良反应的防范。每位患者的身体情况和用药方案均有差异，\u003Cstrong>务必遵循医嘱，主动与医生药师沟通，出现疑问及时反馈\u003C/strong>。\u003Cbr>\u003Cbr>\n      牢记：\u003Cspan class=\"drug-guide-highlight\">绝不擅自更改剂量、擅自增减药物。\u003C/span>\u003Cbr>\n      正确、安全的用药，是有效发挥药物作用最可靠的保障。\n    \u003C/div>\n  \u003C/section>\n  \u003Csection class=\"drug-guide-references\">\n    \u003Ch2 class=\"drug-guide-section-title\">\n      主要参考文献 📚\n    \u003C/h2>\n    \u003Cdiv class=\"drug-guide-section-content\">\n      \u003Cul>\n        \u003Cli>\n          Gamelin, L., Boisdron-Celle, M., Guerin-Meyer, V., et al. (2002). \"Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving FOLFOX4 chemotherapy for advanced colorectal cancer.\" Cancer. 94(7), 2100-2107. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/11932923/\" target=\"_blank\">PubMed\u003C/a>\n        \u003C/li>\n        \u003Cli>\n          Twelves, C., et al. (1999). \"Capecitabine as Adjuvant Treatment for Stage III Colon Cancer.\" New England Journal of Medicine, 350(26), 2696-2703. \u003Ca href=\"https://www.nejm.org/doi/full/10.1056/nejmoa040330\" target=\"_blank\">NEJM\u003C/a>\n        \u003C/li>\n        \u003Cli>\n          Van Cutsem, E., et al. (2009). \"Bevacizumab in combination with chemotherapy as first-line therapy in advanced colon cancer: A review of published studies.\" European Journal of Cancer, 45(6), 258-268. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/19162588/\" target=\"_blank\">PubMed\u003C/a>\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.drug-guide-container {\n  max-width: 890px;\n  margin: 24px auto;\n  background: #f6f8fa;\n  border-radius: 16px;\n  box-shadow: 0 3px 15px rgba(120,150,180,0.09);\n  font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;\n  padding: 32px 28px 48px 28px;\n}\n.drug-guide-title {\n  font-size: 2.2em;\n  font-weight: bold;\n  color: #2c3e50;\n  letter-spacing: 1.5px;\n  text-align: center;\n  margin: 0 0 24px 0;\n  margin-bottom: 30px;\n  border-bottom: 2px solid #d1e6fa;\n  padding-bottom: 18px;\n}\n.drug-guide-intro {\n  font-size: 1.18em;\n  color: #466488;\n  background: linear-gradient(93deg, #e9f2fc 60%, #f4f7fa 100%);\n  border-radius: 10px;\n  padding: 22px 18px;\n  margin-bottom: 36px;\n  line-height: 1.65;\n}\n\n.drug-guide-section {\n  margin-bottom: 42px;\n  position: relative;\n  background-color: #ffffff;\n  border-radius: 15px;\n  box-shadow: 0 1px 8px rgba(175,195,225,0.08);\n  overflow: hidden;\n  padding-bottom: 8px;\n}\n\n.drug-guide-section-title {\n  font-size: 1.35em;\n  color: #155fa0;\n  background: #f2f8fd url('data:image/svg+xml;utf8,\u003Csvg xmlns=\"http://www.w3.org/2000/svg\" width=\"100%\" height=\"56\">\u003Crect fill=\"%23e6f2fb\" x=\"0\" y=\"0\" width=\"100%\" height=\"56\"/>\u003Cellipse fill=\"%23dbeafa\" cx=\"58\" cy=\"44\" rx=\"26\" ry=\"8\"/>\u003Cellipse fill=\"%23deedfa\" cx=\"220\" cy=\"28\" rx=\"42\" ry=\"12\"/>\u003C/svg>');\n  background-repeat: repeat-x;\n  background-size: 100% 56px;\n  padding: 16px 18px 16px 35px;\n  margin: 0 0 0 0;\n  border-left: 6px solid #7bb8f0;\n  text-shadow: 0 1px 1px #f6f9fd;\n  letter-spacing: 0.5px;\n}\n\n.drug-guide-section-bg {\n  height: 10px;\n  width: 100%;\n  background: linear-gradient(90deg,#eaf3fb 60%, #f7f9fc 100%);\n  margin-bottom: 0px;\n}\n\n.drug-guide-section-content {\n  color: #304053;\n  font-size: 1.08em;\n  line-height: 1.7;\n  padding: 18px 24px 18px 35px;\n}\n\n.drug-guide-section-content ul {\n  margin-top: 7px;\n  margin-bottom: 14px;\n  padding-left: 26px;\n}\n.drug-guide-section-content li {\n  margin-bottom: 8px;\n}\n.drug-guide-tip {\n  display: block;\n  margin-top: 16px;\n  background: linear-gradient(90deg, #e2eef8 70%, #f6fafd 100%);\n  color: #175a8a;\n  border-left: 4px solid #6fb7e8;\n  padding: 7px 13px;\n  border-radius: 5px;\n  font-size: 1em;\n}\n.drug-guide-case {\n  display: inline-block;\n  margin: 7px 0;\n  padding: 4px 9px;\n  background: #f7fade;\n  color: #5d660d;\n  border-left: 4px solid #eaca39;\n  border-radius: 4px;\n  font-size: 0.98em;\n}\n.drug-guide-highlight {\n  color: #8f1818;\n  font-weight: bold;\n  background: #ffecec;\n  padding: 2px 7px;\n  border-radius: 4px;\n}\n\n.drug-guide-summary {\n  margin-top: 40px;\n  margin-bottom: 25px;\n  background: #f4faf1;\n  border-radius: 12px;\n  padding: 2px 0 8px 0;\n  box-shadow: 0 1px 6px rgba(90,146,113,0.05);\n}\n\n.drug-guide-references {\n  margin-top: 18px;\n  background: #f3f7fb;\n  border-radius: 11px;\n  padding: 2px 0 8px 0;\n  box-shadow: 0 1px 7px rgba(40,146,196,0.05);\n}\n.drug-guide-references ul {\n  margin-left: 28px;\n}\n.drug-guide-references li {\n  font-size: 0.98em;\n  color: #385573;\n  margin-bottom: 7px;\n}\n@media (max-width: 700px) {\n  .drug-guide-container {\n    padding: 12px 3vw 25px 3vw;\n  }\n  .drug-guide-section-content {\n    padding: 15px 7px 15px 17px;\n    font-size: 1em;\n  }\n  .drug-guide-section-title {\n    font-size: 1.08em;\n    padding: 12px 9px 12px 16px;\n  }\n}\n\u003C/style>","\u003Cdiv class=\"drug-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"drug-guide-title\">\n    结肠癌IV期治疗主",344,"2025-10-25 00:29:02","结肠癌, 化疗药物, 靶向药物, 安全用药, 不良反应处理, 药物相互作用, 老年患者用药","了解结肠癌IV期治疗中化疗和靶向药物的安全使用要点，掌握正确的用药时间、剂型特性及不良反应处理，保护患者健康，确保治疗效果。","2025-12-01 14:30:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]